DE3650734T2 - Pharmazeutische Träger zum Reduzieren des transdermalen Flusses - Google Patents
Pharmazeutische Träger zum Reduzieren des transdermalen FlussesInfo
- Publication number
- DE3650734T2 DE3650734T2 DE3650734T DE3650734T DE3650734T2 DE 3650734 T2 DE3650734 T2 DE 3650734T2 DE 3650734 T DE3650734 T DE 3650734T DE 3650734 T DE3650734 T DE 3650734T DE 3650734 T2 DE3650734 T2 DE 3650734T2
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical carriers
- active agent
- transdermal flow
- pharmacologically active
- reduce transdermal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/29—Antimony or bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/730,682 US4895727A (en) | 1985-05-03 | 1985-05-03 | Pharmaceutical vehicles for exhancing penetration and retention in the skin |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3650734D1 DE3650734D1 (de) | 1999-12-23 |
DE3650734T2 true DE3650734T2 (de) | 2000-04-27 |
Family
ID=24936381
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3650734T Expired - Lifetime DE3650734T2 (de) | 1985-05-03 | 1986-05-02 | Pharmazeutische Träger zum Reduzieren des transdermalen Flusses |
DE3650068T Expired - Lifetime DE3650068T2 (de) | 1985-05-03 | 1986-05-02 | Pharmazeutische träger zum reduzieren des transdermalen flusses. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3650068T Expired - Lifetime DE3650068T2 (de) | 1985-05-03 | 1986-05-02 | Pharmazeutische träger zum reduzieren des transdermalen flusses. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4895727A (de) |
EP (3) | EP0872248A3 (de) |
JP (1) | JPS63500171A (de) |
AT (2) | ATE186644T1 (de) |
AU (2) | AU5906686A (de) |
DE (2) | DE3650734T2 (de) |
FI (1) | FI870013A0 (de) |
WO (1) | WO1986006586A1 (de) |
Families Citing this family (168)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5008294A (en) * | 1985-02-11 | 1991-04-16 | Chemex Pharmaceuticals, Inc. | Methods of treating tumors with compositions of catecholic butanes |
WO1988003805A1 (en) * | 1986-11-19 | 1988-06-02 | Chemex Pharmaceuticals, Inc. | Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts |
US5178851A (en) * | 1987-01-30 | 1993-01-12 | Colgate-Palmolive Company | Antiplaque antibacterial oral composition |
US5156835A (en) * | 1987-01-30 | 1992-10-20 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
US5192531A (en) * | 1988-12-29 | 1993-03-09 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
IN168400B (de) * | 1987-01-30 | 1991-03-23 | Colgate Palmolive Co | |
US5180578A (en) * | 1987-01-30 | 1993-01-19 | Colgate-Palmolive Company | Antibacterial antiplaque anticalculus oral composition |
FR2612774B1 (fr) * | 1987-03-27 | 1990-12-28 | Bfb Etudes Rech Experimentale | Compositions cosmetiques et pharmaceutiques, utilisees pour traiter le processus de l'alopecie androgenogenetique, contenant de l'acide azelaique |
US5202126A (en) * | 1987-08-20 | 1993-04-13 | Parfums Christian Dior | Composition containing pregnenolone or a pregnenolone ester incorporated in liposomes, and a method for regenerating, or revitalizing the skin therewith |
DE3738620A1 (de) * | 1987-11-13 | 1989-05-24 | Luderschmidt Christoph | Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie |
US5066483A (en) * | 1989-03-13 | 1991-11-19 | Vipont Pharmaceutical, Inc. | Oral rinse compositions |
US5411738A (en) * | 1989-03-17 | 1995-05-02 | Hind Health Care, Inc. | Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine |
SE464167B (sv) * | 1989-07-31 | 1991-03-18 | Analytecon Sa | Topisk farmaceutisk beredning av podophyllotoxin |
US4978532A (en) * | 1989-08-11 | 1990-12-18 | Pharmedic Co. | Dosage form for administration of dehydroepiandrosterone |
US5091379A (en) * | 1989-08-31 | 1992-02-25 | Du Pont Merck Pharmaceutical Company | Topical antinflammatory compositions with minimal systemic absorption |
US5196185A (en) * | 1989-09-11 | 1993-03-23 | Micro-Collagen Pharmaceutics, Ltd. | Collagen-based wound dressing and method for applying same |
US5032400A (en) * | 1989-11-02 | 1991-07-16 | Erie Laboratories | Shark liver oil and garlic oil topical analgesic |
US5310546A (en) * | 1990-02-07 | 1994-05-10 | 7-L Corporation | Mouthrinse and method of preparation |
US5174990A (en) * | 1990-02-07 | 1992-12-29 | 7-L Corporation | Mouthrinse and method of preparation |
US5104644A (en) * | 1990-02-07 | 1992-04-14 | 7-L Corporation | Mouthrinse composition |
US5006557A (en) * | 1990-04-19 | 1991-04-09 | Siu Ming Yee | Acne solution |
US5433950A (en) * | 1990-05-07 | 1995-07-18 | Schering-Plough Healthcare Products, Inc. | Flexible collodion compositions |
CA2056803A1 (en) * | 1990-12-06 | 1992-06-07 | Llyr G. Griffiths | Hair treatment composition |
DK0564586T3 (da) * | 1990-12-21 | 2002-07-15 | Felice Bombart | Vandige vaginaludskylninger og beslægtede fremgangsmåder |
US5120325A (en) * | 1991-06-12 | 1992-06-09 | Fleshtones Products Co., Inc. | Color-matched sterile adhesive bandages containing melanin-like pigment composition |
US6033676A (en) * | 1992-03-11 | 2000-03-07 | Joseph B. Taphorn | Treatment of scalp baldness with 8-hydroxyquinoline sulfate |
SG65599A1 (en) * | 1993-03-24 | 1999-06-22 | Collaborative Lab Inc | Cosmetic delivery system for salicylic acid and process for preparation of same |
US5451407A (en) * | 1993-06-21 | 1995-09-19 | Alza Corporation | Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug |
US5411741A (en) * | 1993-07-29 | 1995-05-02 | Zaias; Nardo | Method and composition for skin depigmentation |
US5409691A (en) * | 1993-10-18 | 1995-04-25 | Swain; Dan E. | Solution comprising aluminum acetate and glycerin |
GB2283754B (en) * | 1993-11-11 | 1998-01-28 | Procter & Gamble | Cleaning compositions |
US5545629A (en) * | 1994-04-12 | 1996-08-13 | Montefiore Medical Center | 5-ethoxy-2'-deoxyuridines |
US5496810A (en) * | 1994-04-12 | 1996-03-05 | Montefiore Medical Center | Pyrimidine deoxyribonucleoside potentiation of combination therapy based on 5-fluorouracil and interferon |
US5888984A (en) | 1994-05-12 | 1999-03-30 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
ZA954599B (en) * | 1994-06-07 | 1996-01-26 | Allergan Inc | Stable gel formulation for topical treatment of skin conditions |
US5449519C1 (en) * | 1994-08-09 | 2001-05-01 | Revlon Consumer Prod Corp | Cosmetic compositions having keratolytic and anti-acne activity |
US5547989A (en) * | 1994-08-19 | 1996-08-20 | Schering-Plough Healthcare Products, Inc. | Compositions for treating corns and calluses |
JPH10508856A (ja) * | 1994-11-15 | 1998-09-02 | オスモティクス コーポレーション | スキンケア組成物及びその適用方法 |
US5597550A (en) * | 1994-12-09 | 1997-01-28 | Buxing Mo | Apparatus and method for administering minerals |
FR2728793A1 (fr) * | 1994-12-28 | 1996-07-05 | Oreal | Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue |
US5662883A (en) * | 1995-01-10 | 1997-09-02 | Nanosystems L.L.C. | Microprecipitation of micro-nanoparticulate pharmaceutical agents |
NL9500216A (nl) * | 1995-02-06 | 1996-09-02 | Bio Pharma Sciences Bv | Farmaceutische samenstelling voor de behandeling van herpes. |
TW449485B (en) * | 1995-03-31 | 2001-08-11 | Colgate Palmolive Co | Skin care products containing anti itching/anti irritant agents |
US5575988A (en) * | 1995-04-07 | 1996-11-19 | Littlepoint Corp. | Combination sunscreen and insect repellent |
US5601839A (en) * | 1995-04-26 | 1997-02-11 | Theratech, Inc. | Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
US5648389A (en) * | 1995-10-27 | 1997-07-15 | Medicis Pharmaceutical, Inc. | Compositions for the treatment of dermatological disorders and methods for their use |
US5906814A (en) * | 1995-12-07 | 1999-05-25 | The Andrew Jergens Company | Topical film-forming compositions |
GB9610122D0 (en) * | 1996-05-15 | 1996-07-24 | Reckitt & Colmann Prod Ltd | Organic compositions |
US5667791A (en) * | 1996-05-31 | 1997-09-16 | Thione International, Inc. | X-ray induced skin damage protective composition |
US5716602A (en) * | 1996-06-26 | 1998-02-10 | S. C. Johnson & Sons, Inc. | Insect repellent sunscreen |
US5849800A (en) * | 1997-03-28 | 1998-12-15 | The Penn State Research Foundation | Use of amantadine for treatment of Hepatitis C |
US6127520A (en) | 1997-04-15 | 2000-10-03 | Regents Of The University Of Michigan | Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles |
US5843998A (en) * | 1997-06-30 | 1998-12-01 | Song; Jin | Skin blemish treatment |
US6138683A (en) * | 1997-09-19 | 2000-10-31 | Thione International, Inc. | Smokeless tobacco products containing antioxidants |
US5922346A (en) * | 1997-12-01 | 1999-07-13 | Thione International, Inc. | Antioxidant preparation |
US7846919B2 (en) | 1998-02-10 | 2010-12-07 | Dermex Pharmaceuticals, Llc | Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions |
US6986898B1 (en) * | 1999-06-28 | 2006-01-17 | Ecosmart Technologies, Inc. | Synergistic and residual pesticidal compositions containing plant essential oils with enzyme inhibitors |
US6113929A (en) * | 1998-08-03 | 2000-09-05 | Karl; A. Robert | Composition of matter and method for removing plant resins from skin |
US6264927B1 (en) * | 1998-08-27 | 2001-07-24 | Elmer P. Monahan | Topical solution and method for the treatment of nail fungus |
US6060079A (en) * | 1998-09-09 | 2000-05-09 | Freeman; Frank | Device for topical localized administration of zinc to tissue |
US6602920B2 (en) * | 1998-11-25 | 2003-08-05 | The Texas A&M University System | Method for converting natural gas to liquid hydrocarbons |
US8003782B1 (en) | 1999-02-01 | 2011-08-23 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
US20020150630A1 (en) * | 1999-02-19 | 2002-10-17 | Brooks Norman A. | Zinc chloride composition, unit dose packaging, applicator, and method of use in treating cancer and other skin diseases |
US6558694B2 (en) * | 1999-02-19 | 2003-05-06 | Norman A. Brooks | Zinc chloride unit dose packaging, applicator, and method of use in treating cancer and other skin diseases |
US6702733B1 (en) * | 1999-07-01 | 2004-03-09 | 40 J's Llc | Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds |
US6696078B1 (en) * | 1999-07-21 | 2004-02-24 | Edwin J. Masters | System and methods for local intradermal treatment |
CA2280925A1 (en) * | 1999-07-29 | 2001-01-29 | Bernard Charles Sherman | Stabilized cefuroxime axetil |
US6541517B1 (en) * | 1999-09-03 | 2003-04-01 | Donald M. Murphy | Treatment of skin disorders |
US6759434B2 (en) | 1999-09-22 | 2004-07-06 | B. Ron Johnson | Anti-infective compositions, methods and systems for treating disordered tissue |
US8173709B2 (en) * | 1999-09-22 | 2012-05-08 | Quadex Pharmaceuticals, Llc | Anti-infective methods for treating pathogen-induced disordered tissues |
US6211243B1 (en) | 1999-09-22 | 2001-04-03 | B. Ron Johnson | Methods for treating cold sores with anti-infective compositions |
EP2266607A3 (de) | 1999-10-01 | 2011-04-20 | Immunogen, Inc. | Immunokonjugate für Krebsbehandlung |
US10179159B2 (en) * | 1999-10-22 | 2019-01-15 | Scott Wepfer | Topical anesthetic formulation |
KR100600456B1 (ko) * | 2000-04-18 | 2006-07-13 | 히사미쓰 세이야꾸 가부시키가이샤 | 항염증제 함유 첩부제 |
US20020164381A1 (en) * | 2000-06-30 | 2002-11-07 | Medicis Pharmaceutical Corporation | Mitocidal compositions and methods |
US7879824B2 (en) | 2001-07-31 | 2011-02-01 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
GB0029018D0 (en) * | 2000-11-28 | 2001-01-10 | Strakan Group Plc | Dermatological formulations |
US7326420B2 (en) * | 2001-03-06 | 2008-02-05 | Burkhart Craig G | Benzoyl peroxide compositions having increased potency |
US6737070B1 (en) * | 2001-03-06 | 2004-05-18 | Craig N. Burkhart | Methods of increasing the efficacy of peroxides |
US7357938B2 (en) * | 2001-07-09 | 2008-04-15 | Stiefel Laboratories, Inc. | Sulfacetamide formulations for treatment of rosacea |
US8501202B2 (en) * | 2001-07-09 | 2013-08-06 | Aqua Pharmaceuticals, Llc | Sulfacetamide formulations for treatment of skin dermatoses |
US7022332B2 (en) * | 2001-07-09 | 2006-04-04 | Stiefel Laboratories, Inc. | Sulfacetamide formulations for treatment of rosacea |
US7074832B2 (en) * | 2001-09-24 | 2006-07-11 | Bradley Pharmaceuticals, Inc. | Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use |
US6429231B1 (en) | 2001-09-24 | 2002-08-06 | Bradley Pharmaceuticals, Inc. | Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use |
US20030091540A1 (en) * | 2001-10-16 | 2003-05-15 | Nawaz Ahmad | Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
US6979438B2 (en) | 2002-01-25 | 2005-12-27 | The Procter & Gamble Company | Antiperspirant compositions containing petrolatum |
US20030153619A1 (en) * | 2002-01-29 | 2003-08-14 | Hwang Cheng Shine | Reduction of hair growth |
US7160921B2 (en) | 2002-01-29 | 2007-01-09 | The Gillette Company | Reduction of hair growth |
US20030143195A1 (en) * | 2002-01-30 | 2003-07-31 | Pinsker Judy Senior | Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery |
US6573301B1 (en) * | 2002-04-23 | 2003-06-03 | Bradley Pharmaceuticals, Inc. | Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use |
US20030198616A1 (en) * | 2002-04-23 | 2003-10-23 | Combe Incorporated | Moisturizing skin gel and method |
US20030232094A1 (en) * | 2002-06-12 | 2003-12-18 | Fuller Peter E. | Composition and method for the treatment of skin irritations |
US8232304B2 (en) * | 2002-10-24 | 2012-07-31 | G & R Pharmaceuticals, Llc | Antifungal formulations |
AU2003284337B2 (en) * | 2002-10-25 | 2010-04-15 | Precision Dermatology, Inc. | Modulation of zinc levels to improve tissue properties |
US7374772B2 (en) * | 2002-11-07 | 2008-05-20 | Bommarito Alexander A | Topical antifungal treatment |
US20040247707A1 (en) * | 2003-01-06 | 2004-12-09 | Le Roy Charles Richard | Pearl blue fast acting, long lasting topical pain relief cream |
US20050014730A1 (en) * | 2003-04-02 | 2005-01-20 | Carlson Robert M. | Anti-fungal formulation of triterpene and essential oil |
EP1613295A1 (de) * | 2003-04-15 | 2006-01-11 | Unilever N.V. | Verwendung von alkylresorcinole in der behandlung von acne |
US8734421B2 (en) * | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
GB0320351D0 (en) * | 2003-08-29 | 2003-10-01 | Yates Donald H | A preparation against flying insects that bite |
US6960125B2 (en) * | 2003-11-03 | 2005-11-01 | Jerry Mick | Sanding block |
CA3031283A1 (en) | 2004-01-22 | 2005-08-04 | University Of Miami | Topical co-enzyme q10 formulations and methods of use |
US20050196433A1 (en) * | 2004-03-04 | 2005-09-08 | Brierre Barbara T. | Pharmaceutical composition and method for the transdermal delivery of magnesium |
EP1747033A1 (de) * | 2004-04-30 | 2007-01-31 | Burrell E. Clawson | Gerät und verfahren zur isolierung von bereichen eines menschlichen körpers für lokalisierte kühlung |
US20070244195A1 (en) * | 2004-05-18 | 2007-10-18 | Burkhart Craig N | Treatment methods with peroxides and tertiary amines |
US20060008538A1 (en) * | 2004-07-07 | 2006-01-12 | Wu Jeffrey M | Methods of treating the skin |
US20060078580A1 (en) | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US7740875B2 (en) * | 2004-10-08 | 2010-06-22 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US20060147504A1 (en) * | 2004-12-30 | 2006-07-06 | Bobby Corry | Feminine anti-itch cloth |
CA2595615C (en) * | 2005-01-27 | 2014-05-20 | C.B. Fleet Company Incorporated | Feminine anti-itch gel |
DK1909778T3 (en) * | 2005-07-28 | 2018-03-19 | Academisch Ziekenhuis Bij De Univ Van Amsterdam | Monophenol, benzenediol or sulfhydryl compounds for use in the treatment of melanomas |
US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
US7897800B2 (en) * | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
CA2641420C (en) | 2006-02-03 | 2013-06-25 | Jr Chem, Llc | Anti-aging treatment using copper and zinc compositions |
US20070184130A1 (en) * | 2006-02-03 | 2007-08-09 | Michael Glenn Carrigan | Formulation and method of use for animal ear treatment and homeopathic animal ear treatment |
CA2645073A1 (en) * | 2006-03-08 | 2007-09-13 | Nuviance, Inc. | Transdermal drug delivery compositions and topical compositions for application on the skin |
MX352315B (es) * | 2006-05-02 | 2017-11-17 | Univ Miami | Formulaciones de co-enzima topica q10 y tratamiento de dolor, fatiga y heridas. |
US20070292493A1 (en) * | 2006-06-15 | 2007-12-20 | Brierre Barbara T | Pharmaceutical composition and method for the transdermal delivery of calcium |
US7666859B2 (en) * | 2006-09-08 | 2010-02-23 | Norman Turkowitz | Skin compositions containing hydrocortisone |
US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
US20080124306A1 (en) * | 2006-11-28 | 2008-05-29 | Kiminobu Sugaya | Vigor Enhancement Via Administration of Pyrimidine Derivatives |
MX337408B (es) | 2007-03-22 | 2016-03-03 | Berg Llc | Formulaciones topicas que tienen biodisponibilidad aumentada. |
US7596836B2 (en) * | 2007-05-02 | 2009-10-06 | Schwartz Steve W | Nose and throat anti-influenza solution and method of use |
WO2009072120A1 (en) * | 2007-12-04 | 2009-06-11 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Use of zinc in combination with chemotherapy for treating cancer |
US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
EP2271325A4 (de) | 2008-04-11 | 2011-11-09 | Cytotech Labs Llc | Verfahren und verfwendung zur einleitung von apoptose bei krebszellen |
US20100082088A1 (en) * | 2008-08-27 | 2010-04-01 | Ali Fassih | Treatment of sweating and hyperhydrosis |
WO2010085753A1 (en) | 2009-01-23 | 2010-07-29 | Jr Chem, Llc | Rosacea treatments and kits for performing them |
US20120089232A1 (en) | 2009-03-27 | 2012-04-12 | Jennifer Hagyoung Kang Choi | Medical devices with galvanic particulates |
KR20180056816A (ko) | 2009-05-11 | 2018-05-29 | 베르그 엘엘씨 | 환경대사적 전환인자(조효소 q10)를 사용한 질환의 치료 방법 |
US20110008271A1 (en) * | 2009-07-13 | 2011-01-13 | Jr Chem, Llc | Rosacea treatments using polymetal complexes |
EP2316438A1 (de) | 2009-10-30 | 2011-05-04 | Johnson & Johnson GmbH | Band, insbesondere Klebeband zur Behandlung von Hauterkrankungen mit mindestens einem Hyperkeratosehemmer und/oder mindestens einem keratinolytischem Wirkstoff |
EP2316436A1 (de) | 2009-10-30 | 2011-05-04 | Johnson & Johnson GmbH | Band, insbesondere Klebeband zur Behandlung von Hauterkrankungen mit mindestens einem Film, insbesondere einem löslichen Film, mit mindestens einem Enzym |
KR20110091461A (ko) * | 2010-02-05 | 2011-08-11 | 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 | 갈바니 미립자를 포함하는 립 조성물 |
EP2542209A1 (de) * | 2010-03-01 | 2013-01-09 | Johnson & Johnson Consumer Companies, Inc. | Hautpflegezusammensetzung mit erwünschter farbe in loser form |
EP2544663B1 (de) * | 2010-03-12 | 2018-01-03 | Berg LLC | Intravenöse formulierung aus dem coenzym q10 (coq10) und verwendungsverfahren dafür |
US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
US8846725B2 (en) | 2011-01-24 | 2014-09-30 | Quadex Pharmaceuticals, Llc | Highly penetrating compositions and methods for treating pathogen-induced disordered tissues |
JP6092844B2 (ja) | 2011-04-04 | 2017-03-08 | バーグ エルエルシー | 中枢神経系腫瘍の治療方法 |
MY183615A (en) | 2011-06-17 | 2021-03-03 | Berg Llc | Inhalable pharmaceutical compositions |
WO2013106855A1 (en) * | 2012-01-13 | 2013-07-18 | Larson Brian G | Treatment of skin disease |
CA2880157C (en) | 2012-08-15 | 2020-07-21 | Mimedx Group, Inc. | Reinforced placental tissue grafts and methods of making and using the same |
US9943551B2 (en) | 2012-08-15 | 2018-04-17 | Mimedx Group, Inc. | Tissue grafts composed of micronized placental tissue and methods of making and using the same |
JP2012246324A (ja) * | 2012-09-18 | 2012-12-13 | Sosin:Kk | 皮膚外用剤 |
US9180145B2 (en) | 2012-10-12 | 2015-11-10 | Mimedx Group, Inc. | Compositions and methods for recruiting and localizing stem cells |
US8946163B2 (en) | 2012-11-19 | 2015-02-03 | Mimedx Group, Inc. | Cross-linked collagen comprising metallic anticancer agents |
US9155799B2 (en) | 2012-11-19 | 2015-10-13 | Mimedx Group, Inc. | Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent |
US10206977B1 (en) | 2013-01-18 | 2019-02-19 | Mimedx Group, Inc. | Isolated placental stem cell recruiting factors |
US10111910B2 (en) | 2013-01-18 | 2018-10-30 | Mimedx Group, Inc. | Methods for treating cardiac conditions |
US9125911B2 (en) | 2013-03-14 | 2015-09-08 | Quadex Pharmaceuticals, Llc | Combined systemic and topical treatment of disordered tissues |
US9549930B2 (en) | 2013-03-14 | 2017-01-24 | Quadex Pharmaceuticals, Llc | Combined systemic and topical treatment of disordered and/or prodromal stage tissue |
US9463180B2 (en) | 2013-03-14 | 2016-10-11 | Quadex Pharmaceuticals, Llc | Treatment of molluscum contagiosum |
US10029030B2 (en) | 2013-03-15 | 2018-07-24 | Mimedx Group, Inc. | Molded placental tissue compositions and methods of making and using the same |
NZ713868A (en) | 2013-04-08 | 2021-12-24 | Berg Llc | Treatment of cancer using coenzyme q10 combination therapies |
US10335433B2 (en) | 2013-04-10 | 2019-07-02 | Mimedx Group, Inc. | NDGA polymers and metal complexes thereof |
US9446142B2 (en) | 2013-05-28 | 2016-09-20 | Mimedx Group, Inc. | Polymer chelator conjugates |
CN114209688A (zh) | 2013-08-21 | 2022-03-22 | 威瑞卡制药公司 | 用于治疗皮肤病症的组合物、方法和系统 |
EP3038630B1 (de) | 2013-08-30 | 2020-03-18 | MIMEDX Group Inc. | Mikronisierte plazentale zusammensetzungen mit einem chelatbildner |
SG10201907816RA (en) | 2013-09-04 | 2019-09-27 | Berg Llc | Methods of treatment of cancer by continuous infusion of coenzyme q10 |
WO2015109329A1 (en) | 2014-01-17 | 2015-07-23 | Mimedx Group, Inc. | Method for inducing angiogenesis |
EP3185918B1 (de) | 2014-08-28 | 2021-08-18 | MiMedx Group, Inc. | Collagenverstärkte gewebetransplantate |
US9452178B1 (en) | 2014-10-22 | 2016-09-27 | SatisPharma, LLC | Acne formulations, treatments, and pressure sensitive patches for delivery of acne formulations |
MX2017008097A (es) | 2014-12-17 | 2018-01-09 | Verrica Pharmaceuticals Inc | Sintesis comercialmente viable de cantaridina y derivados bioactivos de cantaridina. |
US11168091B2 (en) | 2015-01-20 | 2021-11-09 | Verrica Pharmaceuticals Inc. | Quantification and preparation of pharmaceutical grade cantharidin |
MA52274A (fr) | 2017-05-17 | 2021-02-24 | Berg Llc | Utilisation de formulations de coenzyme q10 dans le traitement et la prévention de l'épidermolyse bulleuse |
JP7280870B2 (ja) | 2017-06-06 | 2023-05-24 | ヴェリカ ファーマシューティカルズ インコーポレーテッド | 皮膚障害の処置 |
RU2678188C1 (ru) * | 2018-08-31 | 2019-01-24 | Общество с ограниченной ответственностью "Криопротект" | Средство защиты кожи от холодового повреждения |
KR20200124556A (ko) | 2019-04-24 | 2020-11-03 | 삼성전자주식회사 | 펠리클 조립체의 제조 방법 및 포토마스크 조립체의 제조 방법 |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2087162A (en) * | 1935-11-25 | 1937-07-13 | Us Ind Alcohol Co | Perspiration-inhibiting composition |
US2562208A (en) * | 1947-04-14 | 1951-07-31 | Schering Corp | Fungistatic composition |
US2511032A (en) * | 1949-07-07 | 1950-06-13 | Wallace & Tiernan Inc | Zinc salts of mono-olefinic acids as antimycotics |
US3065139A (en) * | 1953-11-12 | 1962-11-20 | Astra Ab | Anti-infectant topical preparations |
GB943282A (en) * | 1960-10-13 | 1963-12-04 | Peter James Shannon | Hair restorer |
FR3691M (fr) * | 1963-05-06 | 1965-11-15 | Olin Mathieson | Nouvelle composition pharmaceutique utile en tant que fongicide. |
US4177267A (en) * | 1963-12-09 | 1979-12-04 | Crown Zellerbach | Enhancing tissue penetration of physiologically active steroidal agents with DMSC |
US3551554A (en) * | 1968-08-16 | 1970-12-29 | Crown Zellerbach Corp | Enhancing tissue penetration of physiologically active agents with dmso |
US3711606A (en) * | 1970-09-02 | 1973-01-16 | Crown Zellerbach Corp | Enhancing tissue penetration of physiologically active steroidal agents with dmso |
US3743727A (en) * | 1970-11-16 | 1973-07-03 | Crown Zellerbach Corp | Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide |
US3949072A (en) * | 1971-03-11 | 1976-04-06 | Tenta Louis T | Topical composition for treatment of seborrheic keratosis |
US3821370A (en) * | 1971-03-11 | 1974-06-28 | L Tenta | Topical composition for treating seborrheic keratosis |
US3930000A (en) * | 1971-06-16 | 1975-12-30 | Univ Washington | Silver-zinc allantoinate compositions and method of killing bacteria and fungi therewith |
US3856805A (en) * | 1971-06-16 | 1974-12-24 | Univ Washington | Silver zinc allantoin complex |
US3790676A (en) * | 1971-09-20 | 1974-02-05 | Merck & Co Inc | Preventing pain,fever and inflammation with cyclic hydroxy sulfoxides |
US3963833A (en) * | 1972-06-02 | 1976-06-15 | Colgate-Palmolive Company | Antiperspirant composition and method containing a dihydro-benzofuran and an astringent metal salt |
US4048300A (en) * | 1973-01-11 | 1977-09-13 | Colgate-Palmolive Company | Dental preparation containing materials having calcium and phosphate components |
US4022880A (en) * | 1973-09-26 | 1977-05-10 | Lever Brothers Company | Anticalculus composition |
US3867528A (en) * | 1973-10-11 | 1975-02-18 | American Cyanamid Co | Steroidal topical cream base |
US3981986A (en) * | 1973-11-23 | 1976-09-21 | Armour Pharmaceutical Company | Zirconium-aluminum-polyol buffered anti-perspirant complexes |
AU513753B2 (en) * | 1974-07-08 | 1980-12-18 | Johnson & Johnson | Antimicrobial composition |
US3996346A (en) * | 1975-03-18 | 1976-12-07 | Dominic Thomas Staffier | Composition for reducing bodily odor and perspiration |
US4049802A (en) * | 1975-03-19 | 1977-09-20 | Research Corporation | Zinc sulfadiazine and its use in the treatment of burns |
US3989815A (en) * | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Novel N-bis-azacyclopentan-2-onyl alkanes |
BE843140A (fr) * | 1975-06-19 | 1976-10-18 | Aazacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients | |
US3989816A (en) * | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacycloheptan-2-ones |
US3991203A (en) * | 1975-06-19 | 1976-11-09 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacyclopentan-2-ones |
US4082841A (en) * | 1975-10-10 | 1978-04-04 | Lever Brothers Company | Dentifrice |
DE2614841A1 (de) * | 1976-04-06 | 1977-10-20 | Bayer Ag | Neue pour-on-formulierungen von anthelmintika |
US4053630A (en) * | 1976-07-07 | 1977-10-11 | Yu Ruey J | Treatment of body odor and disturbed keratinization |
US4199576A (en) * | 1976-12-15 | 1980-04-22 | The Procter & Gamble Company | Analgesic and anti-inflammatory compositions for topical application |
FR2387214A1 (fr) * | 1977-04-14 | 1978-11-10 | Seuref Ag | Derives du p-aminomethyl benzene-sulfonamide, leur procede de preparation et leur application therapeutique |
IT1114950B (it) * | 1977-12-30 | 1986-02-03 | Porro Marcella | Composizioni per il trattamento e la terapia di acne |
US4386104A (en) * | 1977-04-19 | 1983-05-31 | Nazzaro Porro Marcella | Process for the treatment of acne |
US4148924A (en) * | 1977-06-13 | 1979-04-10 | The Procter & Gamble Company | Dermatological compositions |
LU77562A1 (de) * | 1977-06-17 | 1979-03-26 | Ciba Geigy Ag | Verfahren zur herstellung von neuen pharmazeutischen praeparaten |
FR2398495A1 (fr) * | 1977-07-29 | 1979-02-23 | Oreal | Compositions deodorantes contenant un sel de polyacide carboxylique |
US4261982A (en) * | 1977-11-09 | 1981-04-14 | The Procter & Gamble Company | Therapeutic composition |
US4225614A (en) * | 1977-12-21 | 1980-09-30 | Aktiebolaget Draco | Method of treatment for mucocutaneous herpes simplex infections |
US4201235A (en) * | 1978-01-03 | 1980-05-06 | Mare Corporation | Amino acid-vitamin formulations for skin, hair and scalp conditioners |
DE2967049D1 (en) * | 1978-04-11 | 1984-07-19 | Efamol Ltd | Pharmaceutical and dietary composition comprising gamma-linolenic acids |
US4315916A (en) * | 1978-07-18 | 1982-02-16 | Lucille L. Filson | Topical salve |
US4161526A (en) * | 1978-07-20 | 1979-07-17 | Sterling Drug Inc. | Zinc salt prevention or removal of discoloration in pyrithione, pyrithione salt and dipyrithione compositions |
US4229430A (en) * | 1978-08-21 | 1980-10-21 | Fahim Mostafa S | Oral composition for improving oral health |
US4224339A (en) * | 1978-10-10 | 1980-09-23 | Scott Eugene J Van | Treatment of disturbed keratinization |
US4214000A (en) * | 1978-10-30 | 1980-07-22 | Johnson & Johnson | Zinc salt of all-trans-retinoic acid for the treatment of acne |
EP0012115A1 (de) * | 1978-12-04 | 1980-06-11 | Ciba-Geigy Ag | Pharmazeutische Präparate zur topischen Behandlung von Virusinfektionen |
US4335110A (en) * | 1979-08-23 | 1982-06-15 | Orewa Inc. | Pharmaceutical compositions of sanguinaria galangal and zinc chloride |
US4323558A (en) * | 1979-09-10 | 1982-04-06 | Nelson Research & Development Co. | Topical trien containing pharmaceutical compositions and methods of use |
US4330527A (en) * | 1979-11-13 | 1982-05-18 | Teruo Arima | Wound treatment agent |
US4512978A (en) * | 1980-01-24 | 1985-04-23 | Inwood Louis R | Dermatological composition useful in the treatment of psoriasis |
US4349536A (en) * | 1980-03-11 | 1982-09-14 | Hausler Kenneth J | Method of promoting suntan using a cream containing zinc and copper salts |
US4406881A (en) * | 1980-05-20 | 1983-09-27 | Vipont Laboratories | Antimicrobial agent |
US4362745A (en) * | 1980-11-19 | 1982-12-07 | Johnston Frederick B | Medical process and preparation |
US4372296A (en) * | 1980-11-26 | 1983-02-08 | Fahim Mostafa S | Treatment of acne and skin disorders and compositions therefor |
US4356168A (en) * | 1981-05-11 | 1982-10-26 | Colgate-Palmolive Company | Opacified dental cream containing a binary fluorine-providing system |
US4353896A (en) * | 1981-06-08 | 1982-10-12 | Levy Michael A | Penetrating topical medicament |
US4469702A (en) * | 1981-06-23 | 1984-09-04 | Schulte Thomas L | Analgesic composition and use thereof to ameliorate deep and intractable pain |
US4440777A (en) * | 1981-07-07 | 1984-04-03 | Merck & Co., Inc. | Use of eucalyptol for enhancing skin permeation of bio-affecting agents |
US4411893A (en) * | 1981-08-14 | 1983-10-25 | Minnesota Mining And Manufacturing Company | Topical medicament preparations |
US4474763A (en) * | 1982-07-07 | 1984-10-02 | Lubowe Irwin I | Skin preparation |
ZA837627B (en) * | 1982-10-15 | 1984-06-27 | Procter & Gamble | Storage stable topical pharmaceutical composition containing low dielectric solvents |
EP0111058B1 (de) * | 1982-11-26 | 1987-11-04 | Nippon Kayaku Kabushiki Kaisha | Verfahren zur Herstellung von 4'-Demethyl-epipodophylotoxin-beta-D-ethyliden-glucosid und Acylderivate davon |
NZ210840A (en) * | 1984-01-18 | 1987-05-29 | Johnson & Johnson Baby Prod | Composition comprising synergistic combination of miconazole nitrate and zinc oxide |
-
1985
- 1985-05-03 US US06/730,682 patent/US4895727A/en not_active Expired - Lifetime
-
1986
- 1986-05-02 DE DE3650734T patent/DE3650734T2/de not_active Expired - Lifetime
- 1986-05-02 AT AT92201393T patent/ATE186644T1/de not_active IP Right Cessation
- 1986-05-02 AT AT86903757T patent/ATE111355T1/de not_active IP Right Cessation
- 1986-05-02 WO PCT/US1986/000974 patent/WO1986006586A1/en active IP Right Grant
- 1986-05-02 DE DE3650068T patent/DE3650068T2/de not_active Expired - Lifetime
- 1986-05-02 EP EP98105208A patent/EP0872248A3/de not_active Withdrawn
- 1986-05-02 JP JP61502882A patent/JPS63500171A/ja active Pending
- 1986-05-02 EP EP92201393A patent/EP0506207B1/de not_active Expired - Lifetime
- 1986-05-02 EP EP86903757A patent/EP0221176B1/de not_active Expired - Lifetime
- 1986-05-02 AU AU59066/86A patent/AU5906686A/en not_active Abandoned
-
1987
- 1987-01-02 FI FI870013A patent/FI870013A0/fi not_active Application Discontinuation
-
1990
- 1990-05-24 AU AU55883/90A patent/AU627580B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU5588390A (en) | 1990-09-13 |
ATE186644T1 (de) | 1999-12-15 |
EP0872248A3 (de) | 2004-04-28 |
FI870013A (fi) | 1987-01-02 |
DE3650068T2 (de) | 1995-01-19 |
FI870013A0 (fi) | 1987-01-02 |
DE3650734D1 (de) | 1999-12-23 |
JPS63500171A (ja) | 1988-01-21 |
EP0221176B1 (de) | 1994-09-14 |
US4895727A (en) | 1990-01-23 |
AU627580B2 (en) | 1992-08-27 |
EP0872248A2 (de) | 1998-10-21 |
AU5906686A (en) | 1986-12-04 |
EP0506207A2 (de) | 1992-09-30 |
EP0221176A1 (de) | 1987-05-13 |
ATE111355T1 (de) | 1994-09-15 |
EP0506207A3 (en) | 1993-03-03 |
EP0506207B1 (de) | 1999-11-17 |
DE3650068D1 (de) | 1994-10-20 |
EP0221176A4 (de) | 1988-01-25 |
WO1986006586A1 (en) | 1986-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3650734D1 (de) | Pharmazeutische Träger zum Reduzieren des transdermalen Flusses | |
GB2174906B (en) | Topical compositions intended for skin treatment based on salicylic acid derivatives | |
DE3685614T2 (de) | Metallband zum gebrauch in armierten erdbauwerken. | |
IT1209667B (it) | Composizione effeverscente adattivita' analgesica. | |
GR871002B (en) | Pharmaceutical composition for topical use with systemic activity | |
DE3576800D1 (de) | Fusswaermer zum gebrauch im pkw. | |
SE8303003L (sv) | Medel for att oka antitumorverkan hos antitumormedel | |
SE446710B (sv) | Arrangemang for okad karossbredd vid hjulhus pa fordon | |
NO20012624D0 (no) | Topisk sammensetning som inneholder ascomyciner | |
CA2170485A1 (en) | Compositions Containing an Amino Acid Salt of Propionic Acid Non-Steroidal Anti-Inflammatory Agents and Caffeine | |
IT8149623A0 (it) | Derivati encefalinici dotati di attivita' analgesica e composizioni farmaceutiche che li contengono | |
DK0454078T3 (da) | Dobbeltvirkende excipiens til metalchelat-kontrastmidler | |
DE3687283D1 (de) | Mittel zum schutz des gehirns. | |
GB2163051A (en) | Medicinal composition for the treatment or prevention of acne by topical application | |
IT1185014B (it) | Dispositivo per frenare aerodinamicamente movimenti rotatori di un corpo | |
IT8521235A0 (it) | Composti farmacologicamente attivi. | |
BR8303588A (pt) | Aumento de eficacia de inseticidas organicos, sinteticos, soluveis em agua | |
IT8420082A0 (it) | Agenti ad attivita'antibroncospastica e composizioni farmaceutiche che li contengono. | |
DK481885D0 (da) | Slidsvag ophaengningsanordning til hjulaksler for skinnekoeretoejer | |
ATE15645T1 (de) | Als aktiven zusatz alpha-benzylapfelsaeure enthaltende immunomodulatoren. | |
IT1127417B (it) | Composti benzodiazepinici dotati di attivita' sul sistema nervoso cintrale e composizioni farmaceutiche che li contengono | |
SE8404793D0 (sv) | Anordning vid ventil i fordonshjul | |
ATE50119T1 (de) | Traegerkoerper fuer fertigkrawatten und fertigkrawatte. | |
DE3665403D1 (en) | Pharmaceutical composition for topical application | |
RU96102110A (ru) | Способ профилактики и лечения изъязвлений роговицы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |